Manufacturer of Controlled Substances; Notice of Application, 33476 [E9-16521]
Download as PDF
33476
Federal Register / Vol. 74, No. 132 / Monday, July 13, 2009 / Notices
Landing Road, Wilmington, Delaware
19801, made application by letter to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Thebaine (9333), a basic class of
controlled substance listed in schedule
II.
The company plans to import a
Thebaine derivative for the bulk
manufacture of controlled substances
for their customers. The company will
also import analytical reference
standards for distribution to their
customers for research purposes.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic class of controlled substance
may file comments or objections to the
issuance of the proposed registration
and may, at the same time, file a written
request for a hearing on such
application pursuant to 21 CFR 1301.43
and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections
being should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, VA 22152; and must be
filed no later than August 12, 2009.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–16520 Filed 7–10–09; 8:45 am]
mstockstill on DSKH9S0YB1PROD with NOTICES
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
VerDate Nov<24>2008
18:36 Jul 10, 2009
Jkt 217001
this is notice that on May 20, 2009,
Organix Inc., 240 Salem Street, Woburn,
Massachusetts 01801, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Marihuana
(7360), a basic class of controlled
substance listed in schedule I.
The company plans to manufacture a
synthetic cannabinol in bulk for sale to
its customers for research purposes. No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than September 11, 2009.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–16521 Filed 7–10–09; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (09–066)]
Review of U.S. Human Space Flight
Plans Committee; Meeting
AGENCY: National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
SUMMARY: In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
announces a meeting of the Review of
U.S. Human Space Flight Plans
Committee. The agenda topics for the
meeting include:
• Kennedy Space Center Perspective.
• Constellation projects.
• Committee subgroup report.
• Public comment.
DATES: Thursday, July 30, 2009, 8 a.m.–
4 p.m. Note: All times listed are local
times.
ADDRESSES: Hilton Cocoa Beach
Oceanfront, Grand Ballroom, 1550
North Atlantic Avenue, Cocoa Beach,
Florida 32931, 321–799–0003.
FOR FURTHER INFORMATION CONTACT: Mr.
Philip R. McAlister, Office of Program
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Analysis and Evaluation, National
Aeronautics and Space Administration,
Washington, DC 20546. Phone 202–358–
0712.
The
meeting will be open to the public up
to the seating capacity of the room. It is
imperative that the meeting be held on
this date to accommodate the
scheduling priorities of the key
participants.
SUPPLEMENTARY INFORMATION:
P. Diane Rausch,
Advisory Committee Management Officer,
National Aeronautics and Space
Administration.
[FR Doc. E9–16533 Filed 7–10–09; 8:45 am]
BILLING CODE P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (09–064)]
Review of U.S. Human Space Flight
Plans Committee; Meeting
AGENCY: National Aeronautics and
Space Administration.
ACTION:
Notice of meeting.
SUMMARY: In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
announces a meeting of the Review of
U.S. Human Space Flight Plans
Committee. The agenda topics for the
meeting include:
• Johnson Space Center Perspective.
• Constellation projects.
• Committee subgroup report.
• Public comment.
DATES: Tuesday, July 28, 2009, 10 a.m.–
4 p.m. Note: All times listed are local
times.
ADDRESSES: South Shore Harbour Resort
& Conference Center, Crystal Ballroom
Salon A & B, 2500 South Shore Blvd.,
League City, TX 77573, 800–442–5005.
FOR FURTHER INFORMATION CONTACT: Mr.
Philip R. McAlister, Office of Program
Analysis and Evaluation, National
Aeronautics and Space Administration,
Washington, DC 20546. Phone 202–358–
0712.
The
meeting will be open to the public up
to the seating capacity of the room. It is
imperative that the meeting be held on
this date to accommodate the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\13JYN1.SGM
13JYN1
Agencies
[Federal Register Volume 74, Number 132 (Monday, July 13, 2009)]
[Notices]
[Page 33476]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-16521]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on May 20, 2009, Organix Inc.,
240 Salem Street, Woburn, Massachusetts 01801, made application by
letter to the Drug Enforcement Administration (DEA) to be registered as
a bulk manufacturer of Marihuana (7360), a basic class of controlled
substance listed in schedule I.
The company plans to manufacture a synthetic cannabinol in bulk for
sale to its customers for research purposes. No other activity for this
drug code is authorized for this registration.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than September 11, 2009.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-16521 Filed 7-10-09; 8:45 am]
BILLING CODE 4410-09-P